{"meshTags":["Prospective Studies","Neoplasm Staging","Neoplasm Metastasis","Interferon-alpha","Aged","Humans","Immunotherapy, Active","Recombinant Proteins","RNA, Messenger","Sentinel Lymph Node Biopsy","Skin Neoplasms","Antineoplastic Agents","Melanoma","Reverse Transcriptase Polymerase Chain Reaction"],"meshMinor":["Prospective Studies","Neoplasm Staging","Neoplasm Metastasis","Interferon-alpha","Aged","Humans","Immunotherapy, Active","Recombinant Proteins","RNA, Messenger","Sentinel Lymph Node Biopsy","Skin Neoplasms","Antineoplastic Agents","Melanoma","Reverse Transcriptase Polymerase Chain Reaction"],"genes":["interferon alfa-2b"],"publicationTypes":["Clinical Trial","Journal Article","Multicenter Study","Randomized Controlled Trial"],"abstract":"The Sunbelt Melanoma Trial is a prospective randomized trial to evaluate the role of lymph node dissection and adjuvant interferon alfa-2b for patients with early lymph node metastases.","title":"The Sunbelt Melanoma Trial.","pubmedId":"11599897"}